These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19539072)

  • 61. Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function.
    Kini AS; Sarkar K; Rafael OC; Jakkula M; Kaplish D; Lee P; Suleman J; Krishnan P; Kim MC; Sharma SK
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):49-55. PubMed ID: 19288579
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of Two Risk Models in Predicting the Incidence of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention.
    Araujo GN; Wainstein MV; McCabe JM; Huang PH; Govindarajulu US; Resnic FS
    J Interv Cardiol; 2016 Oct; 29(5):447-453. PubMed ID: 27377243
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Incidence of Contrast-Induced Nephropathy After Renal Graft Catheter Arteriography Using Iodine-Based Contrast Medium.
    Fananapazir G; Troppmann C; Corwin MT; Bent CK; Vu CT; Lamba R
    AJR Am J Roentgenol; 2016 Apr; 206(4):783-6. PubMed ID: 26866337
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S; Ko B; Adabag S
    Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
    Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Contrast induced nephropathy in diabetic and non-diabetic patients during coronary angiogram and angioplasty.
    Rahman MM; Haque HS; Banerjee SK; Ahsan SA; Rahman MF; Mahmood M; Salman M; Azam MG
    Mymensingh Med J; 2010 Jul; 19(3):372-6. PubMed ID: 20639829
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
    Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
    Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.
    Watanabe M; Saito Y; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
    J Cardiol; 2016 Nov; 68(5):412-418. PubMed ID: 26708123
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relation of contrast-induced nephropathy to long-term mortality after percutaneous coronary intervention.
    Abe M; Morimoto T; Akao M; Furukawa Y; Nakagawa Y; Shizuta S; Ehara N; Taniguchi R; Doi T; Nishiyama K; Ozasa N; Saito N; Hoshino K; Mitsuoka H; Toma M; Tamura T; Haruna Y; Kita T; Kimura T
    Am J Cardiol; 2014 Aug; 114(3):362-8. PubMed ID: 24927973
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality.
    Marenzi G; Assanelli E; Campodonico J; Lauri G; Marana I; De Metrio M; Moltrasio M; Grazi M; Rubino M; Veglia F; Fabbiocchi F; Bartorelli AL
    Ann Intern Med; 2009 Feb; 150(3):170-7. PubMed ID: 19189906
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Risk factors and prognosis of contrast-induced nephropathy with renal dysfunction].
    Xu H; Chen LM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr; 27(2):232-6. PubMed ID: 15960272
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Validation of a predictive risk score for radiocontrast-induced nephropathy following percutaneous coronary intervention.
    Skelding KA; Best PJ; Bartholomew BA; Lennon RJ; O'Neill WW; Rihal CS
    J Invasive Cardiol; 2007 May; 19(5):229-33. PubMed ID: 17476039
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association of Neutrophil-to-lymphocyte Ratio with Contrast-induced Nephropathy in Patients with Non-ST-elevation Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention.
    Kurtul A; Yarlioglues M; Duran M; Murat SN
    Heart Lung Circ; 2016 Jul; 25(7):683-90. PubMed ID: 26935164
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
    Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
    Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A
    Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of probucol on preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention].
    Suo XQ; Yang SC; Ma ZH; Sun TT; Zhang WY; Cong HL; Lin WH; Lu CZ; Tian FS; Fu NK
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(41):3234-3238. PubMed ID: 29141361
    [No Abstract]   [Full Text] [Related]  

  • 79. Epidemiology of contrast material-induced nephropathy in the era of hydration.
    Balemans CE; Reichert LJ; van Schelven BI; van den Brand JA; Wetzels JF
    Radiology; 2012 Jun; 263(3):706-13. PubMed ID: 22535561
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk factors for contrast-induced nephropathy after coronary angiography.
    Kumar S; Nair RK; Aggarwal N; Abbot AK; Muthukrishnan J; Kumar KV
    Saudi J Kidney Dis Transpl; 2017; 28(2):318-324. PubMed ID: 28352014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.